Gauss Surgical scores $20M to boost adoption of blood loss monitoring platform
The company will also use the Series C funding from Northwell Health, SoftBank Ventures Korea and others to develop new AI-driven applications for the operating room.
The company will also use the Series C funding from Northwell Health, SoftBank Ventures Korea and others to develop new AI-driven applications for the operating room.
Gauss Surgical, Inc., maker of Triton , a platform for real-time monitoring of surgical blood loss using sponges and a digital platform, just announced the close of its $12.6 million in Series B financing. This brings its total funding to $24.6 million.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Promus Ventures led the round and its founding partner, Mike Collett, will serve as a board observer on Gauss Surgical's board of directors.
Fit4D raised $2.8 million, in a filing that appears to be part of its Series A, as it seeks to expand its personalized care plans and coaches beyond diabetes.
Mobile health startup Gauss Surgical has raised $1.5 million through the sale of equity as part of a total offering that could reach more than $2 million, according to a filing with the SEC. The Silicon Valley company recently received FDA approval for its Triton Fluid Management System. The Triton app uses an iPad camera […]